This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JACC Interventions Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, J. W. Articles by Oh, D. J. Search for Related Content PubMed Articles by Kim, J. W. Articles by Oh, D. J.

Six-Month Comparison of Coronary Endothelial Dysfunction Associated With Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent

Cardiovascular Center, Korea University, Guro Hospital, Seoul, Republic of Korea.

^_* Reprint requests and correspondence: Dr. Dong Joo Oh, Guro Hospital, Cardiovascular Center, Korea University, 97 Gurodong-Gil, Guro-gu, Seoul, Republic of Korea, 152-703. (Email: kjwmm{at}medimail.co.kr).

Objectives: This study was designed to investigate whether endothelial dysfunction is related to drug-eluting stent (DES) implantation at 6 months after stenting.

Background: Current available DES could delay vessel healing and subsequently impair endothelial function.

Methods: Endothelial function was estimated at 6-month follow-up in 75 patients (31 men, mean age 62.1 years) with a DES (39 sirolimus-eluting stents [SES], 36 paclitaxel-eluting stents [PES]), and 10 patients with a bare-metal stent (BMS) to the left anterior descending artery, by incremental acetylcholine (Ach) infusion (20 µg/min, 50 µg/min, 100 µg/min) and nitrate (200 µg/min) into the left coronary ostium. Vascular responses were quantitatively measured in arterial segments 5 mm proximal and distal to DES and compared with corresponding segments in the BMS group and midsegments in the left circumflex artery as a reference nonstented artery. All antianginal agents were withheld for at least 72 h before coronary angiography.

Results: Greater vasoconstriction to Ach was observed in both the SES and PES groups than in the BMS group or control segments of left circumflex artery. Vasoconstriction to Ach was more prominent in arterial segments distal to stents in both SES and PES groups compared with those in the BMS group (p < 0.001). The degree of vasoconstriction to Ach was similar between the SES and PES groups. Endothelium-independent vasodilatation to nitrate did not differ significantly between the study groups.

Conclusions: Abnormal vasoconstriction to Ach was found in the SES and PES groups, especially in arterial segments distal to DES at 6 months after stenting, which suggests that DES has a potential long-term adverse effect on local coronary endothelial dysfunction.

Abbreviations and Acronyms   Ach = acetylcholine   ANOVA = analysis of variance   BMS = bare-metal stent(s)   DES = drug-eluting stent(s)   PES = paclitaxel-eluting stent(s)   SES = sirolimus-eluting stent(s)

Related articles in JACC Interventions:

Persistent Endothelial Dysfunction After Drug-Eluting Stents: Another Continuing Cost of Reducing Restenosis

Morton J. Kern
JACC Interventions 2008 1: 72-73. [Full Text]  

This article has been cited by other articles:

				A. P. de Prado, C. Perez-Martinez, C. Cuellas-Ramon, J. M. Gonzalo-Orden, M. Regueiro-Purrinos, B. Martinez, M. J. Garcia-Iglesias, J. M. Ajenjo, J. R. Altonaga, A. Diego-Nieto, et al. Time Course of Reendothelialization of Stents in a Normal Coronary Swine Model: Characterization and Quantification Veterinary Pathology, November 1, 2011; 48(6): 1109 - 1117. [Abstract] [Full Text] [PDF]

				T. Inoue, K. Croce, T. Morooka, M. Sakuma, K. Node, and D. I. Simon Vascular Inflammation and Repair: Implications for Re-Endothelialization, Restenosis, and Stent Thrombosis J. Am. Coll. Cardiol. Intv., October 1, 2011; 4(10): 1057 - 1066. [Abstract] [Full Text] [PDF]

				H. Kaneda Clinical Outcome, Angiographic Outcome, and Coronary Endothelial Function After Drug-Eluting Stent Implantation J. Am. Coll. Cardiol., April 12, 2011; 57(15): 1635 - 1636. [Full Text] [PDF]

				G. Guagliumi, V. Sirbu, H. Bezerra, G. Biondi-Zoccai, L. Fiocca, G. Musumeci, A. Matiashvili, N. Lortkipanidze, S. Tahara, O. Valsecchi, et al. Strut Coverage and Vessel Wall Response to Zotarolimus-Eluting and Bare-Metal Stents Implanted in Patients With ST-Segment Elevation Myocardial Infarction: The OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study J. Am. Coll. Cardiol. Intv., June 1, 2010; 3(6): 680 - 687. [Abstract] [Full Text] [PDF]

				T. Shiroto, S. Yasuda, R. Tsuburaya, Y. Ito, J. Takahashi, K. Ito, H. Ishibashi-Ueda, and H. Shimokawa Role of Rho-Kinase in the Pathogenesis of Coronary Hyperconstricting Responses Induced by Drug-Eluting Stents in Pigs In Vivo J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2321 - 2329. [Abstract] [Full Text] [PDF]

				L. K. Pendyala, X. Yin, J. Li, J. P. Chen, N. Chronos, and D. Hou The First-Generation Drug-Eluting Stents and Coronary Endothelial Dysfunction J. Am. Coll. Cardiol. Intv., December 1, 2009; 2(12): 1169 - 1177. [Abstract] [Full Text] [PDF]

				S. R. Dixon, C. L. Grines, and W. W. O'Neill The Year in Interventional Cardiology J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2080 - 2097. [Full Text] [PDF]

				J. W. Kim, H. S. Seo, J. H. Park, J. O. Na, C. U. Choi, H. E. Lim, E. J. Kim, S.-W. Rha, C. G. Park, and D. J. Oh A Prospective, Randomized, 6-Month Comparison of the Coronary Vasomotor Response Associated With a Zotarolimus- Versus a Sirolimus-Eluting Stent: Differential Recovery of Coronary Endothelial Dysfunction J. Am. Coll. Cardiol., May 5, 2009; 53(18): 1653 - 1659. [Abstract] [Full Text] [PDF]

				C. J. Pepine Provoked Coronary Spasm and Acute Coronary Syndromes J. Am. Coll. Cardiol., August 12, 2008; 52(7): 528 - 530. [Full Text] [PDF]

				T. Shinke, J. Li, J. P. Chen, L. Pendyala, T. Goodchild, R. Jabara, S. Geva, T. Ueno, N. Chronos, K. Robinson, et al. High Incidence of Intramural Thrombus After Overlapping Paclitaxel-Eluting Stent Implantation: Angioscopic and Histopathologic Analysis in Porcine Coronary Arteries Circ Cardiovasc Interv, August 1, 2008; 1(1): 28 - 35. [Abstract] [Full Text] [PDF]

				M. J. Kern Persistent endothelial dysfunction after drug-eluting stents another continuing cost of reducing restenosis. J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 72 - 73. [Full Text] [PDF]